No Detail Found!

Is complete pathological response truly a complete response in breast cancer?

Author(s)
Bushra Rehman Department of Breast Imaging, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Sara Rehman Department of Breast Imaging, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Sameen Mohtasham Department of Surgery, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
Toqeer Zahid Department of Surgery, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
Albash Sarwar Department of Surgery, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
Muhammad Asad Parvaiz Department of Breast Imaging, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Abstract
Objective: To check if complete pathological response in breast cancer is a good prognostic factor. Method: The retrospective study was conducted at the Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan, and comprised data from January 2012 to December 2015 of all patients who received neo-adjuvant chemotherapy and had no distant metastasis at diagnosis. Mastectomy patients were excluded. Complete pathological response was denfied as no detectable tumour cell in breast and axilla on pathological examination of the resected specimen. Tumour characteristics and 5-year disease free survival and overall survival were recorded. Data was analysed using SPSS 20. Results: Of the 353 patients whose data was evaluated, 91(25.8%) had complete pathological response. Mean age at diagnosis was 43±10 years. Among them, 62(68%) patients had grade III tumour, 39(42.9%) were negative for oestrogen receptor, 58(63.7%) were negative for progesterone receptor, 25(27.5%) were positive for human epidermal growth factor receptor 2, and 26(28.6%) patients were triple negative. Overall, 28((30.7%) patients had recurrence; 20(71.4%) had distant metastasis, 6(21.4%) had local recurrence, and 2(7.14%) had contralateral cancer. The 5-year disease-free survival and overall survival rates (Kaplan-Meier Survial curve) were 70% (28 patients-recurrence) and 87% (15 patients-deaths), respectively. Conclusion: Despite complete disappearance of tumour, a signicfiant number of patients developed recurrences.
Publication Details
Page(s) 280-283
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 73, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
Survival, neo-adjuvant chemotherapy, Metastasis., Complete pathological response
0

Citations

0

Downloads

39

Views